RxDoctor Payments Data

Santhosh Upadhyaya

Pediatric Hematology-Oncology · Ann Arbor, MINPI 1770713786

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 1 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Every reported general payment came from a single manufacturer, Novo Nordisk. That places this record below the midpoint for pediatric hematology-oncology clinicians in MI, where the typical reported total is $440.

$39in general payments, 2019–2025

Across 1 payment — averaging $38.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$39
$3,944,089in research payments, 2019–2025

Across 21 payments — averaging $187,814 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Novartis$3.7M
  • Takeda Pharmaceuticals U.S.A., Inc.$250K
  • Novartis Pharma AG$2K

What the payments were for

  • Food & beverage$39100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk1$39

How this compares

$39 in reported general payments places this provider in the 5th percentile of 84 pediatric hematology-oncology providers in Michigan.

See all pediatric hematology-oncology providers in Michigan

Other pediatric hematology-oncology in Ann Arbor

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →